Q3 2022 Sangamo Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Sangamo Therapeutics Third Quarter Earnings Call. (Operator Instructions) Please be advised that this call is being recorded.
I will now turn it over to Louise Wilkie, Head of Corporate Communications and Investor Relations. Please go ahead.
Good afternoon. I'm Louise Wilkie, Sangamo's Vice President of Investor Relations and Corporate Communications. Thank you for joining us on the call today. On this call are several members of Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Operating Officer; Prathyusha Duraibabu, Chief Financial Officer; Jason Fontenot, Chief Scientific Officer; Nathalie Dubois-Stringfellow, Chief Development Officer; and Bettina Cockroft, Chief Medical Officer.
Slides from our corporate presentation can be found on our website, angamo.com, under the Investors & Media section on the Events and Presentations page. This call includes forward-looking statements regarding Sangamo's current expectations.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |